Aa
MedHelp.org will cease operations on May 31, 2024. It has been our pleasure to join you on your health journey for the past 30 years. For more info, click here.
Aa
A
A
A
Close
Avatar universal

Myrcludex B Trial Update?

Hi Guys,
Anyone with update about Myrcludex B trial please update the community.
OCT has been awarded the trial but not much has been heard about the progress.
http://out-clinicaltrials.com/?q=content/oct-starts-phase-2a-multinational-clinical-trial-hepatitis-b-virus-infection
Best Answer
Avatar universal
They will be doing trials in September in several clinics in Moscow. Now it is just naive patients. If the results are promising  it will be opened to many people. They are planning to do large clinical trials all over Russia. Not like here in USA 6 people and years in between stages.

Funds are provided in part by the government there so there will be control over quality and accessibility to the medicine for people that need it.

I really hope they succeed.
29 Responses
Sort by: Helpful Oldest Newest
Avatar universal
indirect update:

" Successful first administration of Myrcludex B, a first-in-class Hepatitis B and D Virus entry inhibitor, in humans " - this is the title for a presentation that will came in AASLD in November (no other info available at this moment)
Helpful - 0
Avatar universal
I know we desperately need something.

All these companies take for ever their pipe line of new drug testing..
Helpful - 0
Avatar universal
Thanks. Something to look forward for the results
Helpful - 0
Avatar universal
if it is promising .. booking ticket to moscow .. to join one group of trials ..
Helpful - 0

You are reading content posted in the Hepatitis B Community

Popular Resources
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.
STIs are the most common cause of genital sores.
Condoms are the most effective way to prevent HIV and STDs.
PrEP is used by people with high risk to prevent HIV infection.